NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: CDIO 32.65%
BioMedNewsBreaks - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Investor Conference Call for Feb. 19, 2026
NYSE: DELL 21.57%
Why Dell Stock Surged Today
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: EDSA 47.03%
$38M Defense Backlog vs. $6M Market Cap, Breakthrough Biotech Data, and the Quantum Security Land Grab
NASDAQ: NGNE 32.65%
NASDAQ: DELL 32.65%
NASDAQ: ACXIF 32.65%
NASDAQ: KORE 32.65%
